AMOEBA (EPA:ALMIB) | WebDisclosure

Basculer en Français

10604	Companies
225013	Keywords
153734	Articles
119072	Press releases

Home
Companies
AMOEBA

PRESS RELEASE

published on 11/18/2025 at 08:00, 7 months 2 days ago

A natural breakthrough in protecting cereals and field crops // Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK
Syngenta and Amoéba partner to develop bio-fungicide for cereals, combating fungal diseases. Planned agreement aims to enhance biological crop protection and sustainability in EU and UK markets

AMOEBA Syngenta Bio-fungicide Cereal Crops Biological Innovation
PRESS RELEASE

published on 11/18/2025 at 08:00, 7 months 2 days ago

Une innovation naturelle dans la protection des céréales et des cultures de plein champ // Syngenta et Amoéba SA vont développer et commercialiser des solutions de biocontrôle pour l'UE et le Royaume-Uni
Un nouveau biofongicide à base d'amibes promet de révolutionner la protection des cultures contre les maladies fongiques, grâce à Syngenta et Amoéba. Une collaboration stratégique pour des solutions innovantes en biocontrôle

AMOEBA Biocontrôle Syngenta Biofongicide Amibes
BRIEF

published on 10/29/2025 at 08:05, 7 months 22 days ago

Amoéba : Bilan Positif des Essais Viticoles 2025

AXPERA Réduction Cuivre Mildiou Essais Viticoles Commercialisation 2026
BRIEF

published on 10/29/2025 at 08:05, 7 months 22 days ago

Amoéba: Positive Results of the 2025 Vine Trials

AXPERA Copper Reduction Viticultural Trials Mildew Commercialization 2026
PRESS RELEASE

published on 10/29/2025 at 08:00, 7 months 22 days ago

Amoéba presents the 2025 results of its vineyard trial campaign: AXPERA confirms its effectiveness against downy mildew and its strong potential to significantly reduce copper use
Amoéba presents 2025 vineyard trial results confirming AXPERA's efficacy against downy mildew. AXPERA's performance in real conditions and response to French regulatory framework highlighted. Market authorization process and commercial launch details shared

AMOEBA Regulatory Framework Market Authorization AXPERA Vineyard Trial
PRESS RELEASE

published on 10/29/2025 at 08:00, 7 months 22 days ago

Amoéba présente le bilan 2025 de sa campagne d'essais viticoles : AXPERA confirme son efficacité contre le mildiou et sa capacité à réduire fortement l'usage du cuivre
Amoéba présente les résultats des essais viticoles 2025 pour AXPERA, confirmant son efficacité contre le mildiou. Cadre réglementaire durci en France, démarches d'homologation en cours pour commercialisation en 2026

AMOEBA Homologation AXPERA Mildiou Essais Viticoles
BRIEF

published on 10/24/2025 at 18:05, 7 months 27 days ago

Amoéba Publie son Rapport Financier Semestriel

AMOEBA Biocontrôle Cosmétique Rapport Financier Amibes Brevetées
BRIEF

published on 10/24/2025 at 18:05, 7 months 27 days ago

Amoéba Publishes its Half-Yearly Financial Report

AMOEBA Financial Report Biocontrol Cosmetic Patented Amoebas
PRESS RELEASE

published on 10/24/2025 at 18:00, 7 months 27 days ago

Amoéba : Mise à disposition du rapport financier semestriel au 30 juin 2025
Amoéba publie son rapport financier semestriel au 30 juin 2025 auprès de l'AMF. Greentech développant des solutions microbiologiques naturelles. Informations consultables sur leur site

AMOEBA AMF Rapport Financier GreenTech Microbiologique
PRESS RELEASE

published on 10/24/2025 at 18:00, 7 months 27 days ago

Amoéba: Publication of the half-year financial report as of June 30, 2025
Amoéba announces the availability of its half-year financial report for the period ending June 30, 2025, filed with the French Financial Markets Authority. The report can be accessed on the company's website

AMOEBA French Financial Markets Authority Half-year Financial Report GreenTech Microbiological Solutions

Accesswire

Published on 06/20/2026 at 01:00, 1 day 3 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 4 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 3 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 3 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 21:25, 7 hours 16 minutes ago

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 22 hours 41 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 8 hours ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 8 hours ago

2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 9 hours ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting

Les Echos

Published on 06/19/2026 at 19:33, 1 day 9 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 9 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 9 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 1 day 9 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE